Ascendis Pharma A/S (ASND) Social Stream
Ascendis Pharma A (ASND) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ASND.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 9 | $216 | $169 | $195.222 | $111.35 | 75.32% |
| 2021-11-15 | 8 | $216 | $169 | $196.666 | $111.35 | 76.62% |
| 2021-11-18 | 9 | $216 | $169 | $196.666 | $111.35 | 76.62% |
| 2021-11-22 | 9 | $216 | $169 | $195.888 | $111.35 | 75.92% |
| 2021-12-08 | 10 | $216 | $169 | $193.9 | $111.35 | 74.14% |
| 2022-01-07 | 10 | $214 | $136 | $185.9 | $111.35 | 66.95% |
| 2022-01-13 | 10 | $214 | $136 | $185.4 | $111.35 | 66.5% |
| 2022-01-25 | 10 | $214 | $136 | $185.7 | $111.35 | 66.77% |
| 2022-01-26 | 10 | $214 | $136 | $185.5 | $111.35 | 66.59% |
| 2022-02-14 | 10 | $214 | $136 | $184.09 | $111.35 | 65.33% |
| 2022-02-23 | 10 | $214 | $128 | $178.545 | $111.35 | 60.35% |
| 2022-03-01 | 11 | $214 | $128 | $179.25 | $111.35 | 60.98% |
| 2022-03-09 | 11 | $214 | $117 | $176.416 | $111.35 | 58.43% |
| 2022-03-15 | 10 | $230 | $117 | $177.666 | $111.35 | 59.56% |
| 2022-03-22 | 10 | $230 | $117 | $179.083 | $111.35 | 60.83% |
The Trend in the Analyst Price Target
Over the past 16 months, ASND's average price target has gone down $16.89.
ASND reports an average of 49.34% for its upside potential over the past 147 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 9 | 216 | 169 | 195.222 | 155.00 | 25.95% |
| 2021-11-18 | 9 | 216 | 169 | 196.666 | 148.64 | 32.31% |
| 2021-11-22 | 9 | 216 | 169 | 195.888 | 142.77 | 37.21% |
| 2022-01-26 | 10 | 214 | 136 | 185.500 | 116.16 | 59.69% |
| 2022-03-18 | 10 | 230 | 117 | 179.083 | 117.44 | 52.49% |
ASND Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 151 days, ASND's average broker recommendation rating improved by 0.11.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ASND has a greater average analyst price target than 1833.81% of all US stocks.
- ASND has a greater number of analysts covering the stock than 1656.32% of Pharmaceutical Products stocks.
- Ascendis Pharma A's upside potential (average analyst target price relative to current price) is greater than 526.68% of Pharmaceutical Products stocks.
- Ascendis Pharma A's variance in analysts' estimates is lower than -573.77% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ARWR, ARVN, and APLS are the three stocks most similar to Ascendis Pharma A regarding the price target and analyst recommendation information presented here.
What is the outlook for ASND? Use POWR Ratings for clearer insight into price direction.